Myocardial revascularisation by laser

被引:7
作者
Owen, AR
Stables, RH
机构
[1] Royal Brompton Hosp, Clin Trials & Evaluat Unit, London SW3 6NP, England
[2] Royal Brompton Hosp, Dept Invas Cardiol, London SW3 6NP, England
关键词
angina; laser revascularisation; TMR; PMR;
D O I
10.1016/S0167-5273(99)00199-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Myocardial revascularisation by laser is an emerging treatment for refractory angina in patients with coronary artery disease that is not amenable to conventional revascularisation. With the original technique, laser energy was applied to epicardial surface of the heart through a lateral thoracotomy; so-called transmyocardial laser revascularisation (TMR). It is now possible, using catheter-based percutaneous myocardial revascularisation (PMR) to deliver laser energy to the myocardium via the endocardial surface. In this article we discuss the possible mechanism of action of laser revascularisation, and summarise the results of recent randomised controlled trials of TMR, PMR systems are described, and the growing evidence for their efficacy is reviewed. (C) 2000 Elsevier Science Ireland Ltd, All rights reserved.
引用
收藏
页码:215 / 220
页数:6
相关论文
共 33 条
[1]   Transmyocardial laser revascularization: Early results and 1-year follow-up [J].
Agarwal, R ;
Ajit, M ;
Kurian, VM ;
Rajan, S ;
Arumugam, SB ;
Cherian, KM .
ANNALS OF THORACIC SURGERY, 1999, 67 (02) :432-436
[2]   Cardiac sympathetic denervation after transmyocardial laser revascularization [J].
Al-Sheikh, T ;
Allen, KB ;
Straka, SP ;
Heimansohn, DA ;
Fain, RL ;
Hutchins, GD ;
Sawada, SG ;
Zipes, DP ;
Engelstein, ED .
CIRCULATION, 1999, 100 (02) :135-140
[3]   Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina [J].
Allen, KB ;
Dowling, RD ;
Fudge, TL ;
Schoettle, GP ;
Selinger, SL ;
Gangahar, DM ;
Angell, WW ;
Petracek, MR ;
Shaar, CJ ;
O'Neill, WW .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (14) :1029-1036
[4]   Isolation of putative progenitor endothelial cells for angiogenesis [J].
Asahara, T ;
Murohara, T ;
Sullivan, A ;
Silver, M ;
vanderZee, R ;
Li, T ;
Witzenbichler, B ;
Schatteman, G ;
Isner, JM .
SCIENCE, 1997, 275 (5302) :964-967
[5]   Factors correlating with risk of mortality after transmyocardial revascularization [J].
Burkhoff, D ;
Wesley, MN ;
Resar, JR ;
Lansing, AM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (01) :55-61
[6]   Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial [J].
Burkhoff, D ;
Schmidt, S ;
Schulman, SP ;
Myers, J ;
Resar, J ;
Becker, LC ;
Weiss, J ;
Jones, JW .
LANCET, 1999, 354 (9182) :885-890
[7]   Histologic appearance of transmyocardial laser channels after 4-1/2 weeks [J].
Burkhoff, D ;
Fisher, PE ;
Apfelbaum, M ;
Kohmoto, T ;
DeRosa, CM ;
Smith, CR .
ANNALS OF THORACIC SURGERY, 1996, 61 (05) :1532-1534
[8]  
COOLEY DA, 1994, TEX HEART I J, V21, P220
[9]  
Dowling RD, 1998, CIRCULATION, V98, pII73
[10]   Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease [J].
Frazier, OH ;
March, RJ ;
Horvath, KA .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (14) :1021-1028